NASDAQ:XRAY
DENTSPLY International Inc. Stock News
$28.12
-0.0600 (-0.213%)
At Close: May 14, 2024
Why the Earnings Surprise Streak Could Continue for Dentsply (XRAY)
05:10pm, Thursday, 10'th Feb 2022 Zacks Investment Research
Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now
03:51pm, Thursday, 10'th Feb 2022 Zacks Investment Research
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
Why the Earnings Surprise Streak Could Continue for Dentsply (XRAY)
01:50pm, Thursday, 10'th Feb 2022
Dentsply (XRAY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now
12:19pm, Thursday, 10'th Feb 2022
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
3 Medical Products Stocks Poised to Beat This Earnings Season
02:49pm, Monday, 07'th Feb 2022 Zacks Investment Research
The Medical Products companies' Q4 results are likely to reflect base business recovery. Let's see how BAX, HSIC, and XRAY are poised ahead of their earnings releases.
3 Medical Products Stocks Poised to Beat This Earnings Season
11:34am, Monday, 07'th Feb 2022
The Medical Products companies' Q4 results are likely to reflect base business recovery. Let's see how BAX, HSIC, and XRAY are poised ahead of their earnings releases.
Did Hedge Funds Catch A Break With DENTSPLY SIRONA Inc. (XRAY)?
10:16pm, Sunday, 06'th Feb 2022 Insider Monkey
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file by the SEC.
Dentsply Sirona To Host Fourth Quarter And Full Year 2021 Conference Call On February 28th
02:18pm, Friday, 04'th Feb 2022 GlobeNewswire Inc.
CHARLOTTE, N.C., Feb. 04, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced today that the Company will be hosting an investor conference call and l
Dentsply Sirona To Host Fourth Quarter And Full Year 2021 Conference Call On February 28th
09:18am, Friday, 04'th Feb 2022
CHARLOTTE, N.C., Feb. 04, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced today that the Company will be hosting an investor conference call and liv
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
03:28pm, Monday, 31'st Jan 2022 Benzinga
Upgrades
UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago quarter EPS of $2.25.
DaVita's (DVA) Collaboration to Aid in Kidney Care Needs
04:09pm, Wednesday, 26'th Jan 2022 Zacks Investment Research
DaVita's (DVA) work with transplant providers and kidney doctors is likely to slow CKD progression and bolster access to home dialysis and kidney transplantation.
Insights on the Dental Cement Global Market to 2026 - Featuring 3M, Cosmedent and Ivoclar Vivadent Among Others - ResearchAndMarkets.com
10:55am, Monday, 10'th Jan 2022 Kwhen Finance
Dentsply Sirona to Present at the 40th Annual J.P. Morgan Healthcare Conference
10:00pm, Thursday, 30'th Dec 2021 GlobeNewswire Inc.
CHARLOTTE, N.C., Dec. 30, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) announced today that the Company will participate virtually in the 40th Annual J.P. M
Dentsply Sirona to Present at the 40th Annual J.P. Morgan Healthcare Conference
05:00pm, Thursday, 30'th Dec 2021
CHARLOTTE, N.C., Dec. 30, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) announced today that the Company will participate virtually in the 40th Annual J.P. Mor
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now
04:02pm, Tuesday, 28'th Dec 2021 Zacks Investment Research
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
